サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1402077

医療用吸入一酸化窒素の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年～2030年、予測

Global Medical Inhaled Nitric Oxide Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
医療用吸入一酸化窒素の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年～2030年、予測
出版日: 2023年12月01日
発行: Value Market Research
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医療用吸入一酸化窒素市場の世界需要は、調査期間2023年～2030年のCAGR8.5%で、2022年の9億8,556万米ドルから2030年には約18億9,287万米ドルの市場規模に達すると推定されます。

医療用吸入一酸化窒素（iNO）は、様々な呼吸器疾患、特に肺高血圧症や低酸素血症（血中酸素濃度が低い）の治療に使用されるガス薬です。酸素化を改善し肺血管障害を管理するための治療的介入として、吸入により投与されます。

市場力学

急性呼吸窮迫症候群（ARDS）や肺高血圧症を含む呼吸器疾患の発生率の増加は、これらの状態を管理し酸素化を促進するための吸入一酸化窒素（iNO）のような治療薬に対する需要を促進しています。新生児医療では、iNOは新生児の持続性肺高血圧症の治療に重要な役割を果たしており、早産児の健康への関心の高まりや新生児医療の進歩と一致しています。ヘルスケア・テクノロジーの進歩、送達システムの改善、モニタリング・ツールは、iNO療法の安全性と有効性を高め、臨床現場での採用を促進しています。肺血管障害の管理と酸素化の改善におけるiNOの臨床的有効性が証明されたことで、医療専門家の間でiNOが受け入れられています。さらに、新たな呼吸器疾患の治療におけるiNOの可能性を探る進行中の研究が、規制当局の支援やヘルスケア支出の増加とともに、市場拡大を後押ししています。

この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を対象としています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、医療用吸入一酸化窒素の世界市場における各セグメントを包括的に評価することもできます。医療用吸入一酸化窒素産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける医療用吸入一酸化窒素市場の現在と将来の需要を強調する地域展望をカバーします。さらに、本レポートでは、著名な全地域における個々の用途セグメントの需要・推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 医療用吸入一酸化窒素 - 産業分析

  • イントロダクション-市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 医療用吸入一酸化窒素の世界市場分析：製品タイプ別

  • 概要：製品タイプ別
  • 実績データと予測データ
  • 分析：製品タイプ別
  • 吸入一酸化窒素デリバリーシステム
  • 一酸化窒素センサーとモニター

第6章 医療用吸入一酸化窒素の世界市場分析：投与経路別

  • 投与経路別概要
  • 実績データと予測データ
  • 投与経路別分析
  • 吸入一酸化窒素ガス
  • 酸素混合吸入一酸化窒素

第7章 医療用吸入一酸化窒素の世界市場分析：用途別

  • 概要：用途別
  • 実績データと予測データ
  • 分析：用途別
  • 心血管疾患
  • 呼吸器疾患

第8章 医療用吸入一酸化窒素の世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • 実績データと予測データ
  • エンドユーザー別分析
  • 病院
  • 診療所

第9章 医療用吸入一酸化窒素の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別売上分析
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第10章 医療用吸入一酸化窒素企業の競合情勢

  • 医療用吸入一酸化窒素市場の競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品発売
  • その他の開発

第11章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Bellerophon Therapeutics
  • Praxair Technology Inc.（Linde plc）
  • Mallinckrodt Pharmaceuticals
  • GE Healthcare
  • Mitsubishi Tanabe Pharma Corporation
  • Vero Biotech LLC
  • Messer Group
  • Air Liquide
  • Nu-Med Plus
  • Beyond Air Inc.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product Type (USD MN)
  • Inhaled Nitric Oxide Delivery Systems Market Sales by Geography (USD MN)
  • Nitric Oxide Sensors and Monitors Market Sales by Geography (USD MN)
  • Analysis Market by Route of Administration (USD MN)
  • Inhaled Nitric Oxide Gas Market Sales by Geography (USD MN)
  • Inhaled Nitric Oxide with Oxygen Mixtures Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Cardiovascular Disorders Market Sales by Geography (USD MN)
  • Respiratory Disorders Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Global Medical Inhaled Nitric Oxide Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Medical Inhaled Nitric Oxide Report
  • Market Research Process
  • Market Research Methodology
  • Global Medical Inhaled Nitric Oxide Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by Route of Administration
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type (USD MN)
  • Inhaled Nitric Oxide Delivery Systems Market Sales by Geography (USD MN)
  • Nitric Oxide Sensors and Monitors Market Sales by Geography (USD MN)
  • Global Market Analysis by Route of Administration (USD MN)
  • Inhaled Nitric Oxide Gas Market Sales by Geography (USD MN)
  • Inhaled Nitric Oxide with Oxygen Mixtures Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Cardiovascular Disorders Market Sales by Geography (USD MN)
  • Respiratory Disorders Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112112999

The global demand for Medical Inhaled Nitric Oxide Market is presumed to reach the market size of nearly USD 1892.87 MN by 2030 from USD 985.56 MN in 2022 with a CAGR of 8.5% under the study period 2023 - 2030.

Medical inhaled nitric oxide (iNO) is a gas medication used in the treatment of various respiratory conditions, particularly those involving pulmonary hypertension or hypoxemia (low blood oxygen levels). It is delivered through inhalation as a therapeutic intervention to improve oxygenation and manage pulmonary vascular disorders.

MARKET DYNAMICS

The increasing incidence of respiratory disorders, including acute respiratory distress syndrome (ARDS) and pulmonary hypertension, propels the demand for therapies like inhaled nitric oxide (iNO) to manage these conditions and enhance oxygenation. Within neonatal care, iNO plays a critical role in treating persistent pulmonary hypertension in neonates, aligning with the heightened focus on preterm infant health and advancements in neonatal care practices. Advancements in healthcare technology, improved delivery systems, and monitoring tools enhance the safety and efficacy of iNO therapy, augmenting its adoption in clinical settings. The proven clinical effectiveness of iNO in managing pulmonary vascular disorders and improving oxygenation fosters its acceptance among healthcare professionals. Moreover, ongoing research exploring iNO's potential in treating additional respiratory conditions, alongside regulatory support and increased healthcare spending, collectively drive market expansion.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of medical inhaled nitric oxide. The growth and trends of medical inhaled nitric oxide industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the medical inhaled nitric oxide market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Inhaled Nitric Oxide Delivery Systems
  • Nitric Oxide Sensors And Monitors

By Route Of Administration

  • Inhaled Nitric Oxide Gas
  • Inhaled Nitric Oxide With Oxygen Mixtures

By Application

  • Cardiovascular Disorders
  • Respiratory Disorders

By End User

  • Hospitals
  • Clinics

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Medical Inhaled Nitric Oxide market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Medical Inhaled Nitric Oxide market include Bellerophon Therapeutics, Praxair Technology Inc. (Linde plc), Mallinckrodt Pharmaceuticals, GE Healthcare, Mitsubishi Tanabe Pharma Corporation, Vero Biotech LLC, Messer Group, Air Liquide, Nu-Med Plus, Beyond Air Inc., and others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . MEDICAL INHALED NITRIC OXIDE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Route of Administration
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End User
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1 Overview by Product Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product Type
  • 5.4 Inhaled Nitric Oxide Delivery Systems Historic and Forecast Sales by Regions
  • 5.5 Nitric Oxide Sensors and Monitors Historic and Forecast Sales by Regions

6 . GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1 Overview by Route of Administration
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Route of Administration
  • 6.4 Inhaled Nitric Oxide Gas Historic and Forecast Sales by Regions
  • 6.5 Inhaled Nitric Oxide with Oxygen Mixtures Historic and Forecast Sales by Regions

7 . GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Cardiovascular Disorders Historic and Forecast Sales by Regions
  • 7.5 Respiratory Disorders Historic and Forecast Sales by Regions

8 . GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET ANALYSIS BY END USER

  • 8.1 Overview by End User
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End User
  • 8.4 Hospitals Historic and Forecast Sales by Regions
  • 8.5 Clinics Historic and Forecast Sales by Regions

9 . GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE MEDICAL INHALED NITRIC OXIDE COMPANIES

  • 10.1. Medical Inhaled Nitric Oxide Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF MEDICAL INHALED NITRIC OXIDE INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Bellerophon Therapeutics
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Praxair Technology Inc. (Linde plc)
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Mallinckrodt Pharmaceuticals
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. GE Healthcare
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Mitsubishi Tanabe Pharma Corporation
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Vero Biotech LLC
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Messer Group
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Air Liquide
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Nu-Med Plus
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Beyond Air Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Others
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies